Keyphrases
4T1 Model
25%
4T1 Tumor Cells
12%
Apoptosis
25%
B-factor
12%
Breast Cancer
12%
Breast Tumor
12%
Breast Tumor Model
12%
Cancer Treatment
12%
CD4 T Cells
12%
CD8+ T Cells
12%
Chemoresistant
12%
Clinical Response
12%
Clinically Significant
12%
Combination Therapy
25%
Curcumin
100%
Current Treatment
12%
Cytotoxic T Cell Response
12%
Dendritic Cell Maturation
12%
Dendritic Cells
25%
DNA Vaccination
25%
DNA Vaccine
12%
Helper T-lymphocytes
12%
Human Breast Cancer
12%
Human Trials
12%
Immature Dendritic Cells
12%
Immune Response
37%
Improved Vaccines
12%
Interleukin-6
75%
Interleukin-6 Inhibitors
12%
Lymph Node Metastasis
12%
Lymph Node Tumour
12%
Mage-b
87%
Metastasis
87%
Metastasis Tumor
12%
Metastatic Breast Cancer
100%
Metastatic Disease
12%
Micrometastasis
12%
Nuclear factor-κB
37%
Preclinical Animal Models
12%
Primary Tumor
25%
Public Health
12%
Regulated Genes
12%
Regulatory T Cells
12%
Specific Intent
12%
Spleen
12%
Survival Time
12%
T Cell Activation
12%
T Cell Unresponsiveness
12%
T Cells
12%
Transcriptional Repressor
12%
Tumor
37%
Tumor Cells
12%
Tumor Size
12%
Tumor Survival
12%
Vaccination
62%
Vaccine Effectiveness
25%
Vaccine Response
12%
Vaccine Strategy
12%
Vaccine Therapy
12%
Medicine and Dentistry
Breast Cancer
100%
Breast Tumor
15%
Cancer Treatment
7%
Cell Differentiation
7%
Clinical Trial
7%
Combination Therapy
15%
Curcumin
61%
Cytotoxic T-Cell
15%
Dendritic Cell
30%
DNA Immunization
23%
Immune Response
23%
Immunity
7%
Immunoglobulin Enhancer Binding Protein
23%
Interleukin 6
53%
Lymph Node Metastasis
7%
Lymphoma
7%
Maturation
7%
Metastatic Breast Cancer
15%
Metastatic Carcinoma
100%
Micrometastasis
7%
Neoplasm
23%
Primary Tumor
15%
Programmed Cell Death
15%
Regulatory T Cell
7%
Spleen Lymph Node
7%
Survival Time
7%
T Cell
15%
T Cell Activation
7%
T-Helper Cell
7%
Tumor Cell
15%
Tumor Model
7%
Vaccine
15%
Immunology and Microbiology
Cell Differentiation
14%
Cytotoxic T Cell
14%
Cytotoxic T-Cell
14%
Dendritic Cell
57%
DNA Immunization
42%
DNA Vaccination
28%
Immune Response
42%
Immunity
14%
Immunoglobulin Enhancer Binding Protein
42%
Immunology
14%
Interleukin 6
100%
Maturation
14%
Mouse Model
14%
Regulatory T Cell
14%
Spleen Lymph Node
14%
STAT3
14%
Survival Time
14%
T Cell
28%
T Cell Activation
14%
T Helper Cell
14%
T-Helper Cell
14%
Tumor Cell
28%
Tumor Volume
14%
Vaccine
28%
Vaccine Efficacy
28%
Vaccine Therapy
14%